The Competitive Intelligence Report
Cancer Peptides as of November 2014 provides a competitor analysis in the
product portfolios and development pipeline of peptide therapeutics for
treatment of cancer. Purchase of the pdf report includes a 6-month online
access to the data of the report and any updates since the publication date.
Credentials to access the database will be sent by e-mail and allow online work
with the project data to print or export an individual report.
Therapeutic cancer peptide therapeutics
in total represent a considerable market size of more than US$ 8 bln in the
year 2013. Major cancer peptide products are of the classes of somatostatin
analogs and agonists and antagonists of the gonadotropin releasing hormone
(GnRH), but also of targeted cancer therapy including proteasome and HDAC
inhibition.
The report provides a compilation of
currently major marketed peptide cancer products and active projects in
research and development for novel cancer peptides.
Competitor
projects are listed in a tabular format providing information on:
- Drug Codes
- Target / Mechanism of Action
- Class of Compound
- Company
- Product Category
- Indication
- R&D Stage
Competitor
Analysis Series:
The Competitor Analysis Series delivers
NO-FRILLS, but concise information about the pipeline of R&D projects for
targets, diseases, technologies and companies at low prices. The information is
provided in a tabular format and fully referenced.
Spanning over 99 pages, “Competitor
Analysis: Cancer Peptides” report covering the 2013 Sales of Major
Cancer Peptides, Somatostatin Analogs, GnRH Analogs: Agonists, GnRH Analogs:
Antagonists, Targeted Cancer Peptides: Proteasome Inhibition, Targeted Cancer
Peptides: HDAC Inhibition, Cytotoxic, Cytostatic or Apoptotic Cancer Peptides, Cancer
Peptide-Drug Conjugates and Peptide Fusion Proteins, Other Cancer Peptides,
Corporate Cancer Peptide R&D Pipelines
Know more about this report
at
– http://mrr.cm/ZCJ
Find
all Pharma and Healthcare Report at: http://www.marketresearchreports.com/pharma-healthcare
For subscription reports visit at: http://www.marketresearchreports.com/subscriptions
No comments:
Post a Comment
Note: only a member of this blog may post a comment.